[quote FitzsimmonsMarvel]@IcedPurple the delivery was due to be ready for the EU in Q1 and the approval has gone through today. The doses were pre-paid for. They were not subject to approval already being granted before their production if you look at the contract. The doses take time to create (obviously given they now can’t meet the order) so yes they should have kept them for use in EU as part of fulfilling their obligation to the EU.
Did you think they were making the million doses in one day before delivery? Clearly they produce them and stockpile them for delivery date.[/quote]
Actually AZ's obligation is to use "best reasonable efforts" to deliver to the EU in Q1. And "best reasonable efforts" is:
"the activities and degree of effort that a company of similar size with a similarly-sized infrastructure and similar resources as AstraZeneca would undertake or use in the development and manufacture of a Vaccine at the relevant stage of development or commercialization having regard to the urgent need for a Vaccine to end a global pandemic".
Stockpiling a vaccine that could be used elsewhere while the EU dawdles through regulatory approval is not having regard to the urgent need for a Vaccine to end a global pandemic.
See also clause 8.1(a):
"AstraZeneca shall notify the Alliance Manager and Representative of each Participating Member State in good time prior to such time that AstraZeneca expects Doses to be available."
It clearly anticipates a ramping up time following regulatory approval, otherwise it would just be an obligation to start delivering as soon as approval is received ("AZ will deliver with 10 days of regulatory approval" or similar).